HLA-A*11:01 is associated with levetiracetam-induced psychiatric adverse events
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HLA-A*11:01 is associated with levetiracetam-induced psychiatric adverse events
Authors
Keywords
Adverse events, Aggression, Epilepsy, Genotyping, Schizophrenia, White blood cells, Drug administration, Psychoses
Journal
PLoS One
Volume 13, Issue 7, Pages e0200812
Publisher
Public Library of Science (PLoS)
Online
2018-07-19
DOI
10.1371/journal.pone.0200812
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study
- (2017) C. Bedetti et al. EUROPEAN JOURNAL OF NEUROLOGY
- Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study
- (2017) Vincenzo Belcastro et al. JOURNAL OF NEUROLOGY
- HLA-B*40:02 and DRB1*04:03 are risk factors for oxcarbazepine-induced maculopapular eruption
- (2016) Jangsup Moon et al. EPILEPSIA
- The HLA-A*2402/Cw*0102 haplotype is associated with lamotrigine-induced maculopapular eruption in the Korean population
- (2015) Jangsup Moon et al. EPILEPSIA
- Self-reported aggressiveness during treatment with levetiracetam correlates with depression
- (2015) Marco Mula et al. EPILEPSY & BEHAVIOR
- The adverse event profile of levetiracetam: A meta-analysis on children and adults
- (2015) Alberto Verrotti et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Generation of human MHC (HLA-A11/DR1) transgenic mice for vaccine evaluation
- (2015) Yang Zeng et al. Human Vaccines & Immunotherapeutics
- Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus-Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma
- (2015) Y. Zheng et al. Cancer Immunology Research
- Meta-Analysis of Randomized Trials on First Line and Adjunctive Levetiracetam
- (2014) Benjamin W. Y. Lo et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Pharmacogenetics of antiepileptic drug-induced hypersensitivity
- (2014) Katarzyna M Bloch et al. PHARMACOGENOMICS
- How does antiepileptic drug induce suicidality? A case associated with levitracetam use
- (2013) Hoo Rim Song et al. GENERAL HOSPITAL PSYCHIATRY
- Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA
- (2012) J. Yun et al. ALLERGY
- Genetic variation in dopaminergic activity is associated with the risk for psychiatric side effects of levetiracetam
- (2012) Christoph Helmstaedter et al. EPILEPSIA
- Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome
- (2012) Chun-Yu Wei et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire
- (2012) D. A. Ostrov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans
- (2011) Sae-Hoon Kim et al. EPILEPSY RESEARCH
- Levetiracetam: a comprehensive review
- (2010) Amy Z Crepeau et al. Expert Review of Neurotherapeutics
- Genetic basis for idiosyncratic reactions to antiepileptic drugs
- (2009) Diego Franciotta et al. CURRENT OPINION IN NEUROLOGY
- Initial Management of Epilepsy
- (2008) Jacqueline A. French et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now